Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL L CANTWELL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1750381059
CMS profile
352058
Location
VINCENNES, IN

General Payments · PY2018–2024

$2,129.81

  • Reported across 147 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$477.26

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $365.77 31
Education $111.49 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $186.69 19
Teva Pharmaceuticals USA, Inc. $161.11 5
ABBVIE INC. $38.57 2
ITI, Inc. $31.00 2
Indivior Inc. $17.55 1
E.R. Squibb & Sons, L.L.C. $14.46 1
Otsuka America Pharmaceutical, Inc. $14.09 1
Alkermes, Inc. $13.79 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $394.39 26
PY2019 $204.24 16
PY2020 $90.92 6
PY2021 $86.40 6
PY2022 $361.24 21
PY2023 $515.36 40
PY2024 $477.26 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.46 04/23/2024 Food and Beverage Undisputed 01/23/2026 1103413093 CMS
ABBVIE INC. $19.11 11/21/2024 Food and Beverage Undisputed 01/23/2026 1103413095 CMS
Alkermes, Inc. $13.79 12/13/2024 Food and Beverage Undisputed 01/23/2026 1124783553 CMS
E.R. Squibb & Sons, L.L.C. $14.46 10/31/2024 Food and Beverage Undisputed 01/23/2026 1101668158 CMS
Indivior Inc. $17.55 04/18/2024 Food and Beverage Undisputed 01/23/2026 1144525404 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.09 01/11/2024 Food and Beverage Undisputed 01/23/2026 1143202632 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.91 07/11/2024 Food and Beverage Undisputed 01/23/2026 1143202636 CMS
Janssen Pharmaceuticals, Inc $8.47 01/04/2024 Food and Beverage Undisputed 01/23/2026 1078021384 CMS
Janssen Pharmaceuticals, Inc $21.38 02/08/2024 Food and Beverage Undisputed 01/23/2026 1078021312 CMS
Janssen Pharmaceuticals, Inc $4.23 02/29/2024 Food and Beverage Undisputed 01/23/2026 1078021266 CMS
Janssen Pharmaceuticals, Inc $5.65 03/01/2024 Food and Beverage Undisputed 01/23/2026 1078021336 CMS
Janssen Pharmaceuticals, Inc $8.47 03/15/2024 Food and Beverage Undisputed 01/23/2026 1078021354 CMS
Janssen Pharmaceuticals, Inc $7.01 04/04/2024 Food and Beverage Undisputed 01/23/2026 1078021308 CMS
Janssen Pharmaceuticals, Inc $7.01 05/23/2024 Food and Beverage Undisputed 01/23/2026 1078021342 CMS
Janssen Pharmaceuticals, Inc $22.09 06/06/2024 Food and Beverage Undisputed 01/23/2026 1078021368 CMS
Janssen Pharmaceuticals, Inc $10.45 06/13/2024 Food and Beverage Undisputed 01/23/2026 1078021304 CMS
Janssen Pharmaceuticals, Inc $8.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 1078021348 CMS
Janssen Pharmaceuticals, Inc $7.67 07/23/2024 Food and Beverage Undisputed 01/23/2026 1078021350 CMS
Janssen Pharmaceuticals, Inc $8.23 08/08/2024 Food and Beverage Undisputed 01/23/2026 1078021326 CMS
Janssen Pharmaceuticals, Inc $8.85 08/22/2024 Food and Beverage Undisputed 01/23/2026 1078021390 CMS
Janssen Pharmaceuticals, Inc $10.42 09/05/2024 Food and Beverage Undisputed 01/23/2026 1078021264 CMS
Janssen Pharmaceuticals, Inc $18.56 09/12/2024 Food and Beverage Undisputed 01/23/2026 1078021358 CMS
Janssen Pharmaceuticals, Inc $6.31 09/19/2024 Food and Beverage Undisputed 01/23/2026 1078021382 CMS
Janssen Pharmaceuticals, Inc $8.16 10/01/2024 Food and Beverage Undisputed 01/23/2026 1078021388 CMS
Janssen Pharmaceuticals, Inc $8.26 10/17/2024 Food and Beverage Undisputed 01/23/2026 1078021286 CMS
Janssen Pharmaceuticals, Inc $7.47 12/11/2024 Food and Beverage Undisputed 01/23/2026 1078021334 CMS
Otsuka America Pharmaceutical, Inc. $14.09 05/23/2024 Food and Beverage Undisputed 01/23/2026 1118870960 CMS
Teva Pharmaceuticals USA, Inc. $14.87 02/15/2024 Food and Beverage Undisputed 01/23/2026 1151707396 CMS
Teva Pharmaceuticals USA, Inc. $18.97 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151707430 CMS
Teva Pharmaceuticals USA, Inc. $111.49 10/11/2024 Education Undisputed 01/23/2026 1151707550 CMS
Teva Pharmaceuticals USA, Inc. $14.54 10/15/2024 Food and Beverage Undisputed 01/23/2026 1151707518 CMS
Teva Pharmaceuticals USA, Inc. $1.24 10/17/2024 Food and Beverage Undisputed 01/23/2026 1151707520 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.